Combined eutexia and amorphization for simultaneous enhancement of dissolution rate of triamterene and hydrochlorothiazide: preparation of orodispersible tablets

References

• National Institute of Diabetes and Digestive and Kidney Diseases (US). LiverTox: clinical and research information on drug-induced liver injury. Bethesda, MD: National Institute of Diabetes and Digestive and Kidney Diseases; 2012.
   Google Scholar
• Niyazov R, Sharman T. Triamterene. In StatPearls [internet]. 2023. StatPearls Publishing.
   Google Scholar
• Tu W, Decker BS, He Z, et al. Triamterene enhances the blood pressure lowering effect of hydrochlorothiazide in patients with hypertension. J Gen Intern Med. 2016;31(1):30–36. doi:10.1007/s11606-015-3469-1.
   PubMed Web of Science ®Google Scholar
• Bovée DM, Visser WJ, Middel I, et al. A randomized trial of distal diuretics versus dietary sodium restriction for hypertension in chronic kidney disease. J Am Soc Nephrol. 2020;31(3):650–662. doi:10.1681/ASN.2019090905.
   PubMed Web of Science ®Google Scholar
• Materson BJ. Insights into intrarenal sites and mechanisms of action of diuretic agents. Am Heart J. 1983;106(1 Pt 2):188–208. doi:10.1016/0002-8703(83)90117-5.
   PubMed Web of Science ®Google Scholar
• Schnaper HW, Freis ED, Friedman RG, et al. Potassium restoration in hypertensive patients made hypokalemic by hydrochlorothiazide. Arch Intern Med. 1989;149(12):2677–2681.
   PubMedGoogle Scholar
• Verma V, Patel P, Ryan KM, et al. Production of hydrochlorothiazide nanoparticles with increased permeability using top-spray coating process. J. Supercrit. Fluids. 2023;192:105788. doi:10.1016/j.supflu.2022.105788.
   Web of Science ®Google Scholar
• Sultan AA, El-Gizawy SA, Osman MA, et al. Self dispersing mixed micelles forming systems for enhanced dissolution and intestinal permeability of hydrochlorothiazide. Colloids Surf B Biointerfaces. 2017;149:206–216. doi:10.1016/j.colsurfb.2016.10.028.
   PubMed Web of Science ®Google Scholar
• Trivedi RV, Admane PS, Taksande JB, et al. Solubility enhancement studies of hydrochlorothiazide by preparing solid dispersions using losartan potassium and urea by different methods. Der Pharmacia Lettre. 2011;3(6):8–17.
   Google Scholar
• El-Gizawy SA, Osman MA, Arafa MF, et al. Aerosil as a novel co-crystal co-former for improving the dissolution rate of hydrochlorothiazide. Int J Pharm. 2015;478(2):773–778. doi:10.1016/j.ijpharm.2014.12.037.
   PubMedGoogle Scholar
• Essa E, Amin M, Sultan A, et al. Hot melt extrusion for enhanced dissolution and intestinal absorption of hydrochlorothiazide. J. Drug Deliv. Sci. Technol. 2023;88:104895. doi:10.1016/j.jddst.2023.104895.
   Web of Science ®Google Scholar
• Vaculikova E, Cernikova A, Placha D, et al. Preparation of hydrochlorothiazide nanoparticles for solubility enhancement. Molecules. 2016;21(8):1005. doi:10.3390/molecules21081005.
   PubMed Web of Science ®Google Scholar
• Cirri M, Maestrini L, Maestrelli F, et al. Design, characterization and in vivo evaluation of nanostructured lipid carriers (NLC) as a new drug delivery system for hydrochlorothiazide oral administration in pediatric therapy. Drug Deliv. 2018;25(1):1910–1921. doi:10.1080/10717544.2018.1529209.
   PubMed Web of Science ®Google Scholar
• Dittert LW, Higuchi T, Reese DR. Phase solubility technique in studying the formation of complex salts of triamterene. J Pharm Sci. 1964;53(11):1325–1328. doi:10.1002/jps.2600531108.
   PubMed Web of Science ®Google Scholar
• Peng B, Wang JR, Mei X. Triamterene–furosemide salt: structural aspects and physicochemical evaluation. Acta Crystallogr B Struct Sci Cryst Eng Mater. 2018;74(6):738–741. doi:10.1107/S2052520618013185.
   Google Scholar
• Fuhr U, Kober S, Zaigler M, et al. Rate-limiting biotransformation of triamterene is mediated by CYP1A2. Int J Clin Pharmacol Ther. 2005;43(7):327–334.
   PubMed Web of Science ®Google Scholar
• Arias MJ, Ginés JM, Moyano JR, et al. Dissolution properties and in vivo behaviour of triamterene in solid dispersions with polyethylene glycols. Pharm Acta Helv. 1996;71(4):229–235. doi:10.1016/s0031-6865(96)00017-9.
   PubMedGoogle Scholar
• Arias MJ, Gines JM, Moyano JR, et al. The application of solid dispersion technique with D-mannitol to the improvement in oral absorption of triamterene. J Drug Target. 1994;2(1):45–51. doi:10.3109/10611869409015892.
   PubMed Web of Science ®Google Scholar
• Arias MJ, Ginés JM, Moyano JR, et al. Influence of the preparation method of solid dispersions on their dissolution rate: study of triamterene-D-mannitol system. Int. J. Pharm. 1995;123(1):25–31. doi:10.1016/0378-5173(95)00026-F.
   Web of Science ®Google Scholar
• Arias MJ, Moyano JR, Ginés JM. Investigation of the triamterene–β-cyclodextrin system prepared by co-grinding. Int. J. Pharm. 1997;153(2):181–189. doi:10.1016/S0378-5173(97)00101-4.
   Google Scholar
• Kohvakka A, Salo H, Gordin A, et al. Antihypertensive and biochemical effects of different doses of hydrochlorothiazide alone or in combination with triamterene. Acta Med Scand. 1986;219(4):381–386. doi:10.1111/j.0954-6820.1986.tb03327.x.
   PubMedGoogle Scholar
• Kant R, Bodla R, Bhutani R, et al. Spectrophotometric absorbance correction method for the estimation of tazobactam and cefepime in combined tablet dosage forms. J. Chem. Pharm. Res. 2015;7(6):648–656.
   Google Scholar
• Shah VP, Walker MA, Prasad VK, et al. Preliminary observations on dissolution and bioavailability of triamterene–hydrochlorothiazide combination products. Biopharm Drug Dispos. 1984;5(1):11–19. doi:10.1002/bdd.2510050103.
   PubMed Web of Science ®Google Scholar
• Khan KA. The concept of dissolution efficiency. J Pharm Pharmacol. 1975;27(1):48–49. doi:10.1111/j.2042-7158.1975.tb09378.x.
   PubMed Web of Science ®Google Scholar
• United States Pharmacopeia 35- National Formulary 30. United States pharmacopeial convention. Rockville (MD); 2012.
   Google Scholar
• Pabari RM, Ramtoola Z. Effect of a disintegration mechanism on wetting, water absorption, and disintegration time of orodispersible tablets. J Young Pharm. 2012;4(3):157–163. doi:10.4103/0975-1483.100021.
   PubMedGoogle Scholar
• Jain CP, Naruka PS. Formulation and evaluation of fast dissolving tablets of valsartan. Int J Pharm and Pharm Sci. 2009;1:219–226.
   Google Scholar
• Mukne AP, Nagarsenker MS. Triamterene-β-cyclodextrin systems: preparation, characterization and in vivo evaluation. AAPS PharmSciTech. 2004;5(1):E19. doi:10.1208/pt050119.
   PubMed Web of Science ®Google Scholar
• Arafa MF, El-Gizawy SA, Osman MA, et al. Xylitol as a potential co-crystal co-former for enhancing dissolution rate of felodipine: preparation and evaluation of sublingual tablets. Pharm Dev Technol. 2018;23(5):454–463. doi:10.1080/10837450.2016.1242625.
   PubMed Web of Science ®Google Scholar
• Narala S, Komanduri N, Nyavanandi D, et al. Hard gelatin capsules containing hot melt extruded solid crystal suspension of carbamazepine for improving dissolution: preparation and in vitro evaluation. J Drug Deliv Sci Technol. 2023;82:104384. doi:10.1016/j.jddst.2023.104384.
   PubMed Web of Science ®Google Scholar
• Elagamy HI, Essa EA, Nouh A, et al. Development and evaluation of rapidly dissolving buccal films of naftopidil: in vitro and in vivo evaluation. Drug Dev Ind Pharm. 2019;45(10):1695–1706. doi:10.1080/03639045.2019.1656734.
   PubMed Web of Science ®Google Scholar
• Hirun N, Kraisit P. Drug-polymers composite matrix tablets: effect of hydroxypropyl methylcellulose (hpmc) k-series on porosity, compatibility, and release behavior of the tablet containing a bcs class i drug. Polymers (Basel). 2022;14(16):3406. doi:10.3390/polym14163406.
   PubMed Web of Science ®Google Scholar
• Onoda H, Inoue Y, Ezawa T, et al. Preparation and characterization of triamterene complex with ascorbic acid derivatives. Drug Dev Ind Pharm. 2020;46(12):2032–2040. doi:10.1080/03639045.2020.1842439.
   PubMed Web of Science ®Google Scholar
• Martins RM, Machado MO, Pereira SV, et al. Microparticulated hydrochlorothiazide solid dispersion: enhancing dissolution properties via spray drying. Drying Technol. 2012;30(9):959–967. doi:10.1080/07373937.2011.652268.
   Web of Science ®Google Scholar
• Delgado M, Navarro M, Lázaro A, et al. Triggering and acceleration of xylitol crystallization by seeding and shearing: rheo-optical and rheological investigation. Sol Energy Mater Sol Cells. 2021;220:110840. doi:10.1016/j.solmat.2020.110840.
   Web of Science ®Google Scholar
• Rani NS, Sannappa J, Demappa T, et al. Effects of CdCl 2 concentration on the structural, thermal and ionic conductivity properties of HPMC polymer electrolyte films. Ionics, 1. 2015; 21:133–140. doi:10.1007/s11581-014-1151-y.
   Web of Science ®Google Scholar
• Abdelquader MM, Essa EA, El Maghraby GM. Inhibition of co-crystallization of olmesartan medoxomil and hydrochlorothiazide for enhanced dissolution rate in their fixed dose combination. AAPS PharmSciTech. 2019;20(1):3. doi:10.1208/s12249-018-1207-9.
   Web of Science ®Google Scholar
• Yu JY, Kim JA, Joung HJ, et al. Preparation and characterization of curcumin solid dispersion using HPMC. J Food Sci. 2020;85(11):3866–3873. doi:10.1111/1750-3841.15489.
   PubMed Web of Science ®Google Scholar
• Alshaikh RA, Essa EA, El Maghraby GM. Eutexia for enhanced dissolution rate and anti-inflammatory activity of nonsteroidal anti-inflammatory agents: caffeine as a melting point modulator. Int J Pharm. 2019;563:395–405. doi:10.1016/j.ijpharm.2019.04.024.
   PubMed Web of Science ®Google Scholar
• Cherukuvada S, Nangia A. Fast dissolving eutectic compositions of two anti-tubercular drugs. CrystEngComm. 2012;14(7):2579–2588. doi:10.1039/c2ce06391c.
   Web of Science ®Google Scholar
• Bazzo GC, Mostafa D, França MT, et al. How tenofovir disoproxil fumarate can impact on solubility and dissolution rate of efavirenz? Int J Pharm. 2019;570:118597. doi:10.1016/j.ijpharm.2019.118597.
   PubMedGoogle Scholar
• El Maghraby GM, Alomrani AH. Synergistic enhancement of itraconazole dissolution by ternary system formation with pluronic F68 and hydroxypropylmethylcellulose. Sci Pharm. 2009;77(2):401–417. doi:10.3797/scipharm.0901-08.
   Google Scholar
• Fan N, He Z, Ma P, et al. Impact of HPMC on inhibiting crystallization and improving permeability of curcumin amorphous solid dispersions. Carbohydr Polym. 2018;181:543–550. doi:10.1016/j.carbpol.2017.12.004.
   PubMed Web of Science ®Google Scholar
• Liu Y, Sun C, Hao Y, et al. Mechanism of dissolution enhancement and bioavailability of poorly water soluble celecoxib by preparing stable amorphous nanoparticles. J Pharm Pharm Sci. 2010;13(4):589–606. doi:10.18433/j3530j.
   PubMed Web of Science ®Google Scholar
• Fan N, Ma P, Wang X, et al. Storage stability and solubilization ability of HPMC in curcumin amorphous solid dispersions formulated by eudragit E100. Carbohydr Polym. 2018;199:492–498. doi:10.1016/j.carbpol.2018.07.036.
   PubMed Web of Science ®Google Scholar
• Marei HF, Arafa MF, Essa EA, et al. Lidocaine as eutectic forming drug for enhanced transdermal delivery of nonsteroidal anti-inflammatory drugs. J. Drug Deliv. Sci. Technol. 2021;61:102338. doi:10.1016/j.jddst.2021.102338.
   Web of Science ®Google Scholar
• Ginés JM, Arias MJ, Novák C, et al. Thermal study of complex formation of triamterene with β-cyclodextrin by spray-drying and co-grinding. J. Therm. Anal. 1995;45(4):659–666. doi:10.1007/BF02548880.
   Google Scholar
• Ma WJ, Chen JM, Jiang L, et al. The delivery of triamterene by cucurbit [7] uril: synthesis, structures and pharmacokinetics study. Mol Pharm. 2013;10(12):4698–4705. doi:10.1021/mp400529m.
   PubMedGoogle Scholar
• Alshaikh RA, Essa EA, El Maghraby GM. Preparation of stabilized submicron fenofibrate crystals on niacin as a hydrophilic hydrotropic carrier. Pharm Dev Technol. 2020;25(2):168–177. doi:10.1080/10837450.2019.1682609.
   PubMed Web of Science ®Google Scholar
• Trasi NS, Purohit HS, Wen H, et al. Non-sink dissolution behavior and solubility limit of commercial tacrolimus amorphous formulations. J Pharm Sci. 2017;106(1):264–272. doi:10.1016/j.xphs.2016.09.016.
   PubMed Web of Science ®Google Scholar
• Mohapatra S, Bose A, Bindhani S, et al. Effect of hydrophilic polymer on solubility and taste masking of linezolid in multi-component cyclodextrin inclusion complex: physicochemical characterization and molecular docking. J. Drug Deliv. Sci. Technol. 2021;66:102876. doi:10.1016/j.jddst.2021.102876.
   Web of Science ®Google Scholar
• Kassem FA, Abdelaziz AE, El Maghraby GM. Ethanol-assisted kneading of apigenin with arginine for enhanced dissolution rate of apigenin: development of rapidly disintegrating tablets. Pharm Dev Technol. 2021;26(6):693–700. doi:10.1080/10837450.2021.1922441.
   PubMed Web of Science ®Google Scholar
• El Maghraby GM, Elsergany RN. Fast disintegrating tablets of nisoldipine for intra-oral administration. Pharm Dev Technol. 2014;19(6):641–650. doi:10.3109/10837450.2013.813543.
   PubMed Web of Science ®Google Scholar
• Dastmalchi S, Garjani A, Maleki N, et al. Enhancing dissolution, serum concentrations and hypoglycemic effect of glibenclamide using solvent deposition technique. J. Pharm. Pharm. Sci. 2005;8(2):175–181.
   PubMed Web of Science ®Google Scholar
• Eisa AM, El-Megrab NA, El-Nahas HM. Formulation and evaluation of fast dissolving tablets of haloperidol solid dispersion. Saudi Pharm J. 2022;30(11):1589–1602. doi:10.1016/j.jsps.2022.09.002.
   PubMed Web of Science ®Google Scholar
• Refaat A, Sokar M, Ismail F, et al. Tadalafil oral disintegrating tablets: an approach to enhance tadalafil dissolution. J. Pharm. Investig. 2015;45(5):481–491. doi:10.1007/s40005-015-0196-x.
   Google Scholar
• Fotaki N, Brown W, Kochling J, et al. Rationale for selection of dissolution media: three case studies. Dissolution Technol. 2013;20(3):6–13. doi:10.14227/DT200313p6.
   Web of Science ®Google Scholar
• FDA. Guidance for industry: orally disintegrating tablets; food and drug administration center for drug evaluation and research. : Silver Spring, MD, USA, 2008.
   Google Scholar
• Chinwala M. Recent formulation advances and therapeutic usefulness of orally disintegrating tablets (ODTs). Pharmacy. 2020;8(4):186. doi:10.3390/pharmacy8040186.
   Web of Science ®Google Scholar
• Beermann B, Groschinsky-Grind M, Rosén A. Absorption, metabolism, and excretion of hydrochlorothiazide. Clin Pharmacol Ther. 1976;19(5 Pt 1):531–537. doi:10.1002/cpt1976195part1531.
   PubMed Web of Science ®Google Scholar